Yin, Ling
Keeler, Geoffrey D.
Zhang, Yuanhui
Hoffman, Brad E.
Ling, Chen http://orcid.org/0000-0003-1527-1471
Qing, Keyun
Srivastava, Arun
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (HL097088, AI122735, EB015684)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 10 December 2019
Revised: 26 February 2020
Accepted: 27 February 2020
First Online: 9 March 2020
Compliance with ethical standards
:
: AS is a cofounder of, and holds equity in, Lacerta Therapeutics, aaVective, KASHX Bio, and Nirvana Therapeutics, and is an inventor on several issued patents on rAAV vectors that have been licensed to various gene therapy companies. All other authors declare no conflict of interests.